Table 1.
Molecule | Modulation of Wnt Signaling Activity |
Effects on GBM Cells and GSCs Properties | Reference |
---|---|---|---|
A: Small molecules | |||
ONC201 | inhibits expression of components of Wnt pathway and Wnt targets | induces apoptosis in GBM cells induces cytotoxicity in chemo- and radiation-resistant GBM patient samples inhibits the growth of GSCs in 3D neurospheres established from human GBM tumors inhibits tumor growth in GBM mouse models |
[121,127] |
SEN461 | induces AXIN stabilization | inhibits anchorage-independent growth of human GBM cell lines and patient-derived primary tumor cells reduces tumor growth in a mouse GBM xenograft model |
[122] |
XAV939 | antagonist of tankyrase-enzymes involved in the degradation of AXIN | decreases the survival and clonogenicity of GBM cells reduces GSC population increases radiosensitization in in vivo radiation model derived from a single human GBM specimen |
[125] |
LiCl SB216763 |
inhibits GSK3β | induces the expression of differentiation markers in GBM cells depletes GSCs population reduces colony formation and induces cell death in GBM cell-lines |
[126] |
G007-LK | inhibitor of tankyrase-enzymes involved in the degradation of AXIN | decreases in vitro proliferation and sphere formation in primary GSC cultures reduction in GSC sphere formation in cotreatment with TMZ |
[124] |
IC261 | inhibitor of CK1 | inhibits growth of GBM cells and GSCs in vitro and induces growth inhibition of human GBM xenografts in mice | [129] |
LGK974 | inhibitor of porcupine proteins that modulate Wnt ligands | acts synergistically with TMZ to inhibit growth of GBM cells | [128] |
ICG-001 | CBP antagonist | reduces proliferation and survival of GBM cells | [123] |
AZD2858 | inhibits GSK-3β | reduces proliferation and survival of GBM cells inhibits the invasion and migration of GBM cells |
[123] |
B: Natural agents | |||
shikonin | inhibits β-catenin phosphorylation | inhibits proliferation, migration and invasion of GBM cells | [131] |
Trichosanthin | inhibits expression of Wnt components | inhibits proliferation, invasion and migration and induces apoptosis of GBM cells | [132] |
R. crenulata root extract | decreases nuclear localization of β-catenin | inhibits proliferation and tumorsphere formation and promotes differentiation of GBM cells | [133] |
resveratrol | decreases expression of Wnt signaling components and Wnt targets | inhibits proliferation, motility and invasion of GSCs | [134] |
carnosic acid | decreases expression of WISP1 | reduces GSC viability suppresses GSC tumorsphere formation inhibits the growth of GSC-derived xenografts |
[135] |
Indirubin | inhibitor of GSK-3β | reduces invasion of GBM and GSC-enriched neurospheres both in vitro and in vivo improves survival of intracranial glioma-bearing mice |
[136] |
DATS | decreases nuclear β-catenin level | inhibits cell growth, induces apoptosis and decreases migration and invasion in GBM cells | [137] |
Sulforaphane | inhibits Wnt/β-catenin signaling | enhances TMZ-induced apoptosis | [138] |
C: Repurposed drugs | |||
NSAIDs diclofenac celecoxib aspirin |
reduces phosphorylation of GSK3β inhibits expression of Wnt targets |
inhibits proliferation, colony formation and migration of GBM cells inhibits proliferation and invasion and induces apoptosis of GBM cells |
[139] [140] |
Niclosamide | decreases concentration of β-catenin in the nucleus | decreases cell viability, exerts antimigratory effects and inhibits the malignant potential of primary GBMs combined treatment with TMZ inhibits viability, stemness, and invasive properties of human GBM tumorspheres and decreases tumor growth in mouse xenograft models |
[141] [142] |
QUE | decreases phosphorylation of GSK3β | suppresses GSCs-initiated tumor growth in mouse models of gliomas acts synergistically with TMZ to suppress growth of TMZ-resistant tumors originated from GSCs |
[143] |
Pioglitazone | inhibits β-catenin expression | reduces cell viability, suppresses invasion and induces apoptosis of GBM cells induces decrease in cell viability and proliferation of GSC lines isolated from GBM patients |
[144] [145] |
LiCl, lithium chloride; DATS, garlic-derived diallyl trisulfide; NSAID, nonsteroidal anti-inflammatory drugs; QUE, Quetiapine.